SUPERNUS PHARMACEUTICALS, INC. - 8-K Filing
Supernus Pharmaceuticals agreed to merge with Indivior on August 1, 2026, creating Supernus, Inc., with stockholders voting for the deal and a $1B special dividend. (Items: 1.01 Entry into a Material Definitive Agreement, 5.02 Compensatory Arrangements of Certain Officers, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $SUPN